• LAST PRICE
    7.5500
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    6.1000/ 1
  • Ask / Lots
    12.0000/ 1
  • Open / Previous Close
    --- / 7.5500
  • Day Range
    ---
  • 52 Week Range
    Low 5.4600
    High 14.8350
  • Volume
    ---
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Friday's close: 7.44
TimeVolumeLUNG
09:32 ET70927.3652
09:33 ET3807.51
09:35 ET29027.418
09:39 ET4037.44
09:42 ET62687.53
09:48 ET12307.39
09:50 ET7007.37
09:51 ET16237.415
09:55 ET44007.38
10:04 ET7967.38
10:08 ET4897.34
10:11 ET2007.37
10:13 ET2007.4
10:20 ET2007.4
10:22 ET56077.44
10:24 ET7007.415
10:27 ET26397.375
10:29 ET9007.39
10:33 ET2167.386
10:38 ET38157.45
10:40 ET10007.48
10:45 ET5007.46
10:47 ET62737.39
10:54 ET1007.43
11:05 ET17947.44
11:07 ET1007.45
11:09 ET1947.47
11:12 ET8007.47
11:14 ET5997.48
11:16 ET8007.44
11:18 ET1007.42
11:21 ET11027.44
11:23 ET6007.45
11:30 ET1397.47
11:34 ET3007.46
11:36 ET18007.43
11:39 ET5007.415
11:41 ET1007.415
11:45 ET3007.44
11:50 ET9497.435
11:52 ET15997.45
11:54 ET2007.43
11:57 ET1317.45
12:01 ET2007.46
12:06 ET2007.46
12:12 ET13637.485
12:19 ET1007.48
12:21 ET34677.48
12:26 ET3567.47
12:28 ET4007.47
12:30 ET1007.47
12:32 ET12007.47
12:33 ET1007.48
12:39 ET1007.48
12:44 ET4337.491
12:46 ET1007.49
12:48 ET13007.5
12:50 ET1167.5
12:51 ET4007.5
12:53 ET6007.51
01:00 ET5527.51
01:02 ET16547.485
01:08 ET62927.47
01:09 ET19257.48
01:13 ET3007.46
01:15 ET1007.465
01:20 ET1007.47
01:22 ET8417.45
01:24 ET2007.44
01:27 ET1007.43
01:29 ET5307.4782
01:33 ET2007.48
01:36 ET7007.49
01:38 ET5007.5
01:40 ET26027.5
01:42 ET4007.5
01:44 ET14007.5
01:45 ET1007.5
01:47 ET12897.505
01:49 ET27677.515
01:51 ET5007.515
01:54 ET10137.505
01:56 ET2007.5
01:58 ET5007.5
02:02 ET1007.5
02:03 ET20407.5
02:05 ET8007.505
02:07 ET1007.51
02:09 ET1007.5
02:12 ET3007.52
02:14 ET8007.5
02:16 ET2127.5
02:18 ET1007.5
02:20 ET6007.49
02:21 ET1007.5
02:30 ET12537.49
02:32 ET15007.48
02:36 ET4287.47
02:39 ET2007.45
02:41 ET9317.43
02:43 ET19687.4016
02:45 ET5007.3938
02:48 ET4007.39
02:50 ET11257.43
02:54 ET3007.44
02:56 ET1007.43
03:01 ET13587.42
03:03 ET6007.415
03:06 ET2077.4449
03:10 ET1007.44
03:14 ET7597.45
03:15 ET3007.48
03:19 ET5587.48
03:21 ET1007.47
03:24 ET6007.49
03:28 ET3007.49
03:30 ET1007.47
03:32 ET9007.46
03:33 ET1007.46
03:35 ET3007.485
03:39 ET3007.49
03:42 ET18007.5
03:44 ET10007.48
03:46 ET16007.48
03:50 ET5007.47
03:51 ET20007.48
03:53 ET12727.485
03:55 ET24717.46
03:57 ET19137.49
04:00 ET402247.55
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesLUNG
Pulmonx Corp
298.1M
-5.1x
---
United StatesUTMD
Utah Medical Products Inc
238.3M
15.8x
+2.27%
United StatesSGHT
Sight Sciences Inc
230.9M
-4.3x
---
United StatesSMLR
Semler Scientific Inc
378.9M
25.4x
+31.99%
United StatesDCTH
Delcath Systems Inc
318.5M
-3.9x
---
United StatesZJYL
Jin Medical International Ltd
252.0M
86.4x
+21.92%
As of 2024-11-12

Company Information

Pulmonx Corporation is a commercial-stage medical technology company. The Company provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease. Its solutions, which is comprised of the Zephyr Endobronchial Valve (Zephyr Valve), the Chartis Pulmonary Assessment System (Chartis System) and the StratX Lung Analysis Platform (StratX Platform), is designed to treat severe emphysema patients. The StratX Platform is a cloud-based quantitative CT analysis service that offers physicians with a report that is designed for its solution, which includes information on emphysema destruction, fissure completeness and lobar volume to help identify target lobes for treatment with Zephyr Valves. The Chartis System is a balloon catheter and console system with flow and pressure sensors designed to assess the presence of collateral ventilation and has been validated in multiple randomized controlled clinical trials.

Contact Information

Headquarters
700 Chesapeake DrREDWOOD CITY, CA, United States 94063
Phone
650-934-2600
Fax
302-655-5049

Executives

Independent Chairman of Board
Dana Mead
President, Chief Executive Officer, Director
Steven Williamson
Chief Financial Officer, Principal Financial and Chief Accounting Officer
Mehul Joshi
General Counsel
David Lehman
Chief Commercial Officer
Geoffrey Rose

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$298.1M
Revenue (TTM)
$79.3M
Shares Outstanding
39.5M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.76
EPS
$-1.47
Book Value
$3.07
P/E Ratio
-5.1x
Price/Sales (TTM)
3.8
Price/Cash Flow (TTM)
---
Operating Margin
-73.40%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.